Chris Rivard

Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial

Jamie E. Chaft, Filiz Öezkan, Mark G. Kris et al. · Nature Medicine · 2022 · 237 citations · Full text

Medicine, Oncology, Pharmacology +17

Minimal change disease: a “two-hit” podocyte immune disorder?

Michiko Shimada, Carlos E. Araya, Chris Rivard et al. · Pediatric Nephrology · 2010 · 120 citations

Life Sciences, Immunology, Pathology +12

Oral fructose absorption in obese children with non‐alcoholic fatty liver disease

Jillian S. Sullivan, Morehouse Le, Zhaoxing Pan et al. · Pediatric Obesity · 2014 · 64 citations

Medicine, Nutrition, Pediatrics +17

Toll-like receptor 3 ligand, polyIC, induces proteinuria and glomerular CD80, and increases urinary CD80 in mice

Takuji Ishimoto, Michiko Shimada, Gabriela Muñoz G. et al. · Nephrology Dialysis Transplantation · 2012 · 58 citations · Full text

Medicine, Immunology, Nephrology +16

Fructokinase, Fructans, Intestinal Permeability, and Metabolic Syndrome: An Equine Connection?

Richard J. Johnson, Chris Rivard, Miguel A. Lanaspa et al. · Journal of Equine Veterinary Science · 2012 · 55 citations

Life Sciences, Nutrition, Nutritional Sciences +16